As of April 10, 2026, Tata 1mg Technologies Private Limited, Unlisted Shares are trading at ₹103,047.00 per share and face value is ₹1.00/share, with a 52-week high of ₹103,047.00 and 52-week low of ₹103,047.00. The minimun lot size is None shares, and the shares are traded on .
ISIN
INE0BLN01018
An International Securities Identification Number (ISIN) is a code that uniquely identifies a specific securities issue. The numbers are allocated by a country's respective national numbering agency (NNA).
Face Value
1
Value of a security, as stated by its issuer. It has no relation with market price of the stock.
Total Shares
8,48,338
Total shares or total number of shares outstanding represents the amount of stock on the open market, including shares held by institutional investors and restricted shares held by insiders and company officers.
Market Cap
8,741.87 Cr
Market capitalization is the aggregate valuation of the company based on its current share price and the total number of outstanding shares.
Sector
Technology
A sector is an area in which businesses share the same or a related product or service. It can also be known as an industry or market that shares common operating characteristics
Sub-sector
Health Tech
Subsectors are the divisions of a sector. They are areas that vary from the rest of the sector substantially enough to justify creating a plan just for the subsector.
Category
Unicorn
Category is defined as a class or division of things regarded as having particular shared characteristics.
About Tata 1mg
Company Overview:
Tata 1mg is a leading healthcare platform in India, providing a wide range of services, including online pharmacy, diagnostics, e-consultation, and health content. The company was initially focused on providing information on medicines and helping people use their medicines effectively and safely. In 2016, 1mg launched its online pharmacy business, and in 2017, it launched its diagnostics business.
Tata 1mg offers a wide range of medicines and healthcare products, including prescription medicines, over-the-counter medicines, and health supplements. It also offers a wide range of diagnostic tests, including blood tests, urine tests, and imaging tests. Tata 1mg's e-consultation service allows patients to book appointments online and consult with doctors from a variety of specialties over video calls or chat. The company also publishes a health content library that includes articles, videos, and infographics on a wide range of health topics, such as disease prevention, treatment options, and healthy living.
Tata 1mg is a subsidiary of Tata Digital Limited, a subsidiary of Tata Sons, which is part of the Tata Group, one of India's largest and most respected conglomerates. In December 2020, Tata Digital acquired a majority stake in 1mg, leading to the rebranding of the platform as "Tata 1mg."
Tata 1mg has a customer base is over 10 million, with over 1,00,000 medicines and healthcare products on its platform. The company also has more than 10,000 partner pharmacies across India. Also, the company offers a wide range of diagnostic tests, including blood tests, urine tests, and imaging tests.
1mg was founded in 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan. It initially started as HealthKartPlus, a platform that provided information about medicines and their substitutes. HealthKartPlus later rebranded itself as "1mg" to emphasize its focus on providing healthcare solutions, including medicines, health information, and diagnostic services.
Tata 1mg is committed to making healthcare accessible, understandable, and affordable for all Indians. The company is playing a leading role in the transformation of the Indian healthcare sector through its innovative and customer-centric services. Also, has been recognized for its innovative healthcare services and has won numerous awards, including the "Best Healthcare Company" award at the India Digital Awards 2022.
Tata 1mg has a strong presence in over 1,000 cities in India. Its registered office is located at Level 3, Vasant Square Mall, Pocket V, Sector B, Vasant Kunj New Delhi South Delhi DL 110070.
Want to See a Detailed Investment Analysis?
Explore in-depth financial analysis, performance metrics, and key disclosures.
Tata 1mg Media
News
Articles
Videos
Khyaal and Tata 1mg join hands to empower Senior citizens with Holistic Healthcare Solutions
18 Sep 2023
• Your Story
Health financing startup Kenko signs partnership with Tata 1mg
21 Aug 2023
• Mint
Tata 1mg revenue up to ₹1,627 cr, loss widens to ₹1,254 cr